MONTICELLO - Kirby Medical Center’s Auxiliary held its annual luncheon on Monday, July 11 at the Monticello Community Building. Almost 100 members and guests attended, including family members of newly-elected
Merck have announced the launch of the BioContinuum™ Seed Train Platform, the industry’s only integrated and versatile solution enabling biomanufacturers to confidently move toward next generation bioprocessing using seed train intensification. Click to read more.
Share this article
Share this article
NEW YORK, Feb. 24, 2021 /PRNewswire/ Award winning market research company Fact.MR has recently published a report on the global serological transplant diagnostics market. According to the study, the market is expected to receive significant impetus in 2021 as organ transplantation procedures acquire momentum after a brief lull experienced due to the COVID-19 pandemic. Long-term prospects appear modest, with Fact.MR projecting a CAGR of 2.5% through 2031.
Growth is majorly underpinned by increasing incidences of nephrology disorders. According to the Global Burden of Disease (GBD) study published in 2015, 1.2 million people succumbed to kidney failure, representing an increase of 32% since 2005. Furthermore, in 2010, approximately 2.3 to 7.1 million people died of end stage kidney disease, without access to chronic dialysis. In addition, kidney diseases compels high-income countries to allocate over 2-3% of annual healthcare budget for their